Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last $ 52.86 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Agios Pharmaceuticals Inc | AGIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 1.31 | 2.54% | 52.86 | 53.27 | 51.7055 | 51.75 | 51.55 | 00:00:01 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 45.70 | 76.00 | 30.30 | 39.87% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 15,458 | 1,621,424 | $ 52.62 | $ 85,326,467 | 812,515 | 28.36 - 69.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 17:45:39 | priorref | 9,875 | $ 52.86 | USD |
Agios Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 3.61B | 68.37M | $ -346.03M | -6.03 | - | 67.52M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Agios Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AGIO Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 48.76 | 53.27 | 44.30 | 49.01 | 1,036,837 | 4.10 | 8.41% |
| 1 Month | 48.08 | 53.27 | 44.30 | 48.84 | 723,699 | 4.78 | 9.94% |
| 3 Months | 31.82 | 53.27 | 28.36 | 40.00 | 952,201 | 21.04 | 66.12% |
| 6 Months | 47.23 | 53.27 | 28.36 | 39.23 | 742,759 | 5.63 | 11.92% |
| 1 Year | 55.86 | 69.64 | 28.36 | 45.25 | 619,056 | -3.00 | -5.37% |
| 3 Years | 43.51 | 99.8242 | 28.36 | 56.77 | 526,209 | 9.35 | 21.49% |
| 5 Years | 133.60 | 133.80 | 28.36 | 61.19 | 584,931 | -80.74 | -60.43% |
Agios Pharmaceuticals Description
| Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval. |
